Opana Buyers Want Pay-For-Delay Trial Split In 3
Buyers who say they overpaid for the prescription painkiller Opana ER want their pay-for-delay fight with Endo Pharmaceuticals and Impax Laboratories sliced into three separate trials, the buyers told an Illinois...To view the full article, register now.
Already a subscriber? Click here to view full article